Spectrum Pharmaceuticals/ US84763A1088 /
| 2023-07-31 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.03USD | - | 122,550 Turnover: 124,444.33 |
-Bid Size: - | -Ask Size: - | 211.42 mill.USD | - | - |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | - | 2.7000 | 2.5000 | 1.5000 | 1.4050 | ||||||
| Intangible Assets | - | 41.7000 | 202.3000 | 231.4000 | 230.1000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 267.5640 | ||||||
| Inventories | - | 10.8000 | 14.5000 | 13.5000 | 9.2000 | ||||||
| Accounts Receivable | - | 51.7000 | 92.2000 | 49.5000 | 70.7580 | ||||||
| Cash and Cash Equivalents | - | 121.2000 | 139.7000 | 156.3000 | 129.9420 | ||||||
| Current Assets | - | 225.8000 | 264.9000 | 235.2000 | 222.4690 | ||||||
| Total Assets | - | 280.8000 | 506.3000 | 499.2000 | 490.0330 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | 54.8000 | 95.3000 | 79.8000 | 8.9940 | ||||||
| Long-term debt | - | - | 75 | - | 96.2980 | ||||||
| Liabilities to Banks | - | 0.0000 | 75 | 0.0000 | 0.0000 | ||||||
| Provisions | - | 14 | 2.9000 | 7.2000 | 6.6000 | ||||||
| Liabilities | - | 92.9000 | 221.4000 | 217.5000 | 235.4790 | ||||||
| Share Capital | - | .0590 | .0600 | .0640 | .0660 | ||||||
| Total Equity | - | 187.9000 | 284.8000 | 281.6000 | 254.5540 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | - | 280.8000 | 506.3000 | 499.2000 | 490.0330 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 74.1000 | 193 | 267.7000 | 155.9000 | 186.8300 | ||||||
| Depreciation (total) | 3.7000 | 3.7000 | 6.7000 | 20.1000 | 25.3520 | ||||||
| Operating Result | -52.9000 | 55.1000 | 79.8000 | -38.8000 | -31.5690 | ||||||
| Interest Income | - | - | - | -2.2000 | -8.5840 | ||||||
| Income Before Taxes | -48.9000 | 52.2000 | 79 | -36.6000 | -43.5330 | ||||||
| Income Taxes | 0.0000 | 3.7000 | -15.6000 | 25.5000 | -2.1860 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -48.8000 | 48.5000 | 95.5000 | -62.1000 | -45.7190 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -22.5000 | 43.3000 | 72 | -2.1000 | -3.6270 | ||||||
| Cash Flow from Investing Activities | -9.8000 | .7000 | -114.7000 | -14.3000 | -21.8410 | ||||||
| Cash Flow from Financing | 3.6000 | 23.6000 | 61 | 35.3000 | .8120 | ||||||
| Decrease / Increase in Cash | -28.8000 | 67.6000 | 18.5000 | 16.6000 | -26.3640 | ||||||
| Employees | 139 | 176 | 193 | 226 | 241 | ||||||
